Achillion Pharmaceuticals Inc - Strategic SWOT Analysis Review

Achillion Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Achillion Pharmaceuticals Inc (Achillion), a subsidiary of Alexion Pharmaceuticals Inc, is a biopharmaceutical company that focuses on the discovery and development of small molecule therapeutic products for treatment of infectious diseases and immune system related disorders. The company focuses on developing life-saving medicines for patients with rare diseases. It is developing oral antiviral therapy for chronic hepatitis C (HCV) and a platform of potent and specific complement inhibitors. Achillion intends to develop and commercialize factor D inhibitors for rare diseases including paroxysmal nocturnal hemoglobinuria (PNH), C3 Glomerulopathy (C3G), dry age-related macular degeneration (dry AMD). Achillion is headquartered in New Haven, Connecticut, the US.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.




Section 1 - About the Company
Achillion Pharmaceuticals Inc - Key Facts
Achillion Pharmaceuticals Inc - Key Employees
Achillion Pharmaceuticals Inc - Key Employee Biographies
Achillion Pharmaceuticals Inc - Major Products and Services
Achillion Pharmaceuticals Inc - History
Achillion Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Achillion Pharmaceuticals Inc - Business Description
Achillion Pharmaceuticals Inc - Corporate Strategy
Achillion Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Achillion Pharmaceuticals Inc - Strengths
Achillion Pharmaceuticals Inc - Weaknesses
Achillion Pharmaceuticals Inc - Opportunities
Achillion Pharmaceuticals Inc - Threats
Achillion Pharmaceuticals Inc - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Achillion Pharmaceuticals Inc, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer


List Of Tables


Achillion Pharmaceuticals Inc, Key Facts
Achillion Pharmaceuticals Inc, Key Employees
Achillion Pharmaceuticals Inc, Key Employee Biographies
Achillion Pharmaceuticals Inc, Major Products and Services
Achillion Pharmaceuticals Inc, History
Achillion Pharmaceuticals Inc, Other Locations
Achillion Pharmaceuticals Inc, Key Competitors
Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Achillion Pharmaceuticals Inc, Recent Deals Summary


List Of Figures


Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


Achillion Pharmaceuticals Inc - Strategic SWOT Analysis Review

Achillion Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Achillion Pharmaceuticals Inc (ACHN) - Financial and Strategic SWOT Analysis Review

Achillion Pharmaceuticals Inc (ACHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Rocket Pharmaceuticals Inc (RCKT) - Financial and Strategic SWOT Analysis Review

Rocket Pharmaceuticals Inc (Rocket Pharma), formerly Inotek Pharmaceuticals Corp is a clinical-stage biopharmaceutical company. It focuses on the discovery and development of novel therapeutics for the treatment of glaucoma and

USD 300 View Report

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available